Compare Quest Diagnostics Inc (DGX) vs Packaging Corporation of America (PKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Packaging Corporation of America — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.80B), while Packaging Corporation of America trades at $225.8 (market cap $20.11B). The key difference: Quest Diagnostics Inc and Packaging Corporation of America are close in size by market cap, and Packaging Corporation of America pays the higher dividend (2.66%). Which is the better fit depends on your goals.
| DGX | PKG | |
|---|---|---|
Market Cap | $22.80B | $20.11B |
Sector | Health | Technology |
52-Week High | $216.02 | $246.31 |
52-Week Low | $166.42 | $191.41 |
Enterprise Value | $28.82B | $23.94B |
Dividend Yield | 1.67% | 2.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
Packaging Corporation of America (PKG) trades at $225.86, down 1.27% on the day, with a bearish technical signal but oversold RSI near support at $225. Recent Q1 2026 earnings beat expectations with EPS of $2.40, though revenue growth is modest and net income margins are projected to decline. The company announced a 20% dividend increase to $6.00 annually, signaling confidence in cash flow. Analyst consensus is mixed with a Hold rating but a $254.43 price target implies 13% upside from current levels.
Outlook is cautiously optimistic given valuation support from dividends and earnings beats, but risks include margin pressure from input costs and a negative net cash flow trend. The stock's investment case hinges on execution against Q2 guidance of $2.33 EPS and management's ability to navigate cost inflation. Near-term price action will be driven by the July 23 earnings call results.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
